Evidence map›Paper›PMID 34665930›Full record

ArticleCancer communications (London, England)2021

Licochalcone A suppresses Sp1 expression with potential anti-myeloma activity.

Hua Bai, Min Zhou, He Zhou, Qiaoyan Han, Han Xu, Peipei Xu, Bing Chen

Open access · goldAbstract readLetterComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancer communications (London, England), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Hua BaiDepartment of Hematology, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, Jiangsu, 210008, P. R. China.ORCID 0000-0003-0849-524X
Min ZhouDepartment of Hematology, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, Jiangsu, 210008, P. R. China.
He ZhouNanjing Drum Tower Hospital Clinical College of Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, 210008, P. R. China.
Qiaoyan HanNanjing Drum Tower Hospital Clinical College of Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, 210008, P. R. China.
Han XuSchool of Medicine, Southeast University, Nanjing, Jiangsu, 210008, P. R. China.
Peipei XuDepartment of Hematology, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, Jiangsu, 210008, P. R. China.
Bing ChenDepartment of Hematology, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, Jiangsu, 210008, P. R. China.
Nanjing Drum Tower Hospital · CNNanjing University of Chinese Medicine · CNSoutheast University · CN

Funding

National Natural Science Foundation of China 82000215
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ChalconesMultiple MyelomaHumansSp1 Transcription FactorChalconeslicochalcone ASP1 protein, humanSp1 Transcription Factor

Identifiers

PMID34665930
PMCPMC8626604
OpenAlexW3207609899

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.